insurance coverage for semaglutide just changed as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss. https://www.wkrg.com/news/glp-1-insurance-change-impacts-millions-of-americans-what-to-know-how-to-tell-if Novo's top US exec wants

For weight maintenance: Aim to consume around your TDEE

The European Medicines Agency (EMA) assessment reports note that gastrointestinal adverse effects are typically most pronounced during dose escalation and often improve with continued use

GLP-1 medications may influence inflammation, insulin signaling, and other biologic pathways that could matter for cancer development and progression

Sponsor: Martin, Brock Full bill history + details: Automated legislative tracking by LegisGo #TNLeg #TennesseePolitics To view or add a comment, sign in BILL PASSED | HB0484 Passed Senate, Ayes 30, Nays 0 As introduced, requires health benefit plans and TennCare health benefit plans to cover biomarker testing on and after January 1, 2026